Literature DB >> 19133491

Understanding the clinical profile of a drug on the basis of its pharmacology: mirtazapine as an example.

Robert H Howland1.   

Abstract

Direct comparisons of different drugs used for the same indication can reveal important differences in efficacy or tolerability. Such clinical differences can often be explained or predicted on the basis of the particular pharmacological properties of each drug. To demonstrate the clinical importance of understanding the distinct pharmacology of a drug, this article describes the pharmacology and clinical profile of mirtazapine (Remeron). Mirtazapine is a pharmacologically unique agent among antidepressant drugs. Clinical studies have demonstrated similar overall efficacy for mirtazapine compared with the serotonin reuptake inhibitors and with venlafaxine (Effexor), but a more rapid onset of antidepressant effect and a substantially different side effect profile. Knowledge about drug pharmacology leads to better understanding of the differences in the efficacy and tolerability of various drugs. This knowledge also provides a rationale for choosing one drug over another for a particular patient or switching or combining drugs for treating nonresponders or alleviating side effects.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133491     DOI: 10.3928/02793695-20081201-07

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  2 in total

1.  Pharmacokinetics of mirtazapine and its main metabolites after single intravenous and oral administrations in rats at two dose rates.

Authors:  Mohammad-Reza Rouini; Hoda Lavasani; Behjat Sheikholeslami; Helen Owen; Mario Giorgi
Journal:  Daru       Date:  2014-01-07       Impact factor: 3.117

2.  Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.

Authors:  Robert H Howland
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-16       Impact factor: 2.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.